106 related articles for article (PubMed ID: 8968472)
1. Comment: compatibility of amphotericin B with lipid emulsions.
Montoro JB; López RM; Pou L
Ann Pharmacother; 1996 Dec; 30(12):1501. PubMed ID: 8968472
[No Abstract] [Full Text] [Related]
2. Precipitation of amphotericin B from i.v. fat emulsion.
Heide PE
Am J Health Syst Pharm; 1997 Jun; 54(12):1449. PubMed ID: 9194992
[No Abstract] [Full Text] [Related]
3. Amphotericin B formulated in a lipid emulsion.
Cleary JD
Ann Pharmacother; 1996 Apr; 30(4):409-12. PubMed ID: 8729899
[No Abstract] [Full Text] [Related]
4. [Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].
Blancard A; Monges P; Lacarelle B; Denis JP; Bongrand MC; Ragon CH; Gouin F
Pathol Biol (Paris); 1996 May; 44(5):384-8. PubMed ID: 8758481
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B intralipid formulation: stability and particle size.
Ranchère JY; Latour JF; Fuhrmann C; Lagallarde C; Loreuil F
J Antimicrob Chemother; 1996 Jun; 37(6):1165-9. PubMed ID: 8836819
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B does not mix with fat emulsion.
Trissel LA
Am J Health Syst Pharm; 1995 Jul; 52(13):1463-4. PubMed ID: 7671046
[No Abstract] [Full Text] [Related]
7. Stability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsion.
Owens D; Fleming RA; Restino MS; Cruz JM; Hurd DD
Am J Health Syst Pharm; 1997 Mar; 54(6):683-6. PubMed ID: 9075499
[No Abstract] [Full Text] [Related]
8. Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion.
Lopez RM; Ayestaran A; Pou L; Montoro JB; Hernandez M; Caragol I
Am J Health Syst Pharm; 1996 Nov; 53(22):2724-7. PubMed ID: 8931814
[TBL] [Abstract][Full Text] [Related]
9. Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.
Schmidt S; Müller RH
Int J Pharm; 2003 Mar; 254(1):3-5. PubMed ID: 12615399
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B infused in 20% lipid emulsion.
Ryan KA
J Intraven Nurs; 1996; 19(3):123-5. PubMed ID: 8788829
[TBL] [Abstract][Full Text] [Related]
11. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B in fat emulsion.
Kintzel PE
Am J Health Syst Pharm; 1996 Nov; 53(22):2701. PubMed ID: 8931810
[No Abstract] [Full Text] [Related]
13. Acute renal failure with amphotericin B in lipid emulsion.
Gales MA; Gales BJ; Alford KM
Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
[No Abstract] [Full Text] [Related]
14. Comments concerning 'The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasis'.
Washington C; Davis SS
Biopharm Drug Dispos; 1995 Aug; 16(6):529-31. PubMed ID: 7579034
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of Intralipid emulsions of amphotericin B.
Herbrecht R; Letscher V
J Antimicrob Chemother; 1997 Jul; 40(1):137-9. PubMed ID: 9249219
[No Abstract] [Full Text] [Related]
16. Amphotericin B is incompatible with lipid emulsions.
Ericsson O; Hallmen AC; Wikstrom I
Ann Pharmacother; 1996 Mar; 30(3):298. PubMed ID: 8833570
[No Abstract] [Full Text] [Related]
17. Comment: expense of amphotericin B product.
Andersen JM
Ann Pharmacother; 1996 Nov; 30(11):1342. PubMed ID: 8913426
[No Abstract] [Full Text] [Related]
18. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B, its lipid formulations and conjugates with polymers.
Kubicová L; Pravda M; Buchta V; Voprsalová M; Sedlák M
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S54-6. PubMed ID: 15141979
[TBL] [Abstract][Full Text] [Related]
20. ALERT: mix-ups between conventional and lipid formulations of amphotericin B can be extremely dangerous.
Koczmara C; Richardson H; Hyland S; Lee CS; Hillebrand N
Dynamics; 2011; 22(1):24-6. PubMed ID: 21469498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
